BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 21, 2015
 |  BioCentury  |  Finance

Appetite for white space

Why Lux thinks the time is right to focus on the gut-brain axis

Lux Capital has decided signaling between the gut and brain represents investable white space. The firm led a $44 million series A round last week for Kallyope Inc., which plans to develop therapies that act on the gut-brain axis for metabolic and psychological conditions.

Other investors included Polaris Partners, The Column Group, Illumina Inc. (NASDAQ:ILMN), Tony Evnin and Alexandria Venture Investments. Evnin invested as an individual, not as a partner at Venrock.

"There are 300 million neurons in...

Read the full 393 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >